These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33336293)

  • 21. [Role and application of programmed death protein 1 (PD-1) and its ligand PD-L1 in immune cell dysfunction in sepsis: An update].
    Ding Y; Dai L; Xiang Y; Sun Y; Yu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):843-848. PubMed ID: 32967768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis.
    Suzuki T; Suzuki Y; Okuda J; Kurazumi T; Suhara T; Ueda T; Nagata H; Morisaki H
    J Intensive Care; 2017; 5():22. PubMed ID: 28270914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the understanding and treatment of sepsis-induced immunosuppression.
    Venet F; Monneret G
    Nat Rev Nephrol; 2018 Feb; 14(2):121-137. PubMed ID: 29225343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis.
    Wisnoski N; Chung CS; Chen Y; Huang X; Ayala A
    Shock; 2007 Mar; 27(3):251-7. PubMed ID: 17304105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
    Delano MJ; Ward PA
    J Clin Invest; 2016 Jan; 126(1):23-31. PubMed ID: 26727230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defects in innate and adaptive immunity in patients with sepsis and health care associated infection.
    Ryan T; Coakley JD; Martin-Loeches I
    Ann Transl Med; 2017 Nov; 5(22):447. PubMed ID: 29264364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-7 and Its Beneficial Role in Sepsis-Induced T Lymphocyte Dysfunction.
    de Roquetaillade C; Monneret G; Gossez M; Venet F
    Crit Rev Immunol; 2018; 38(6):433-451. PubMed ID: 31002599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cells with immunoregulatory properties and their impact in the pathogenesis of sepsis].
    Diosa-Toro MA; Jaimes B FA; Rugeles L MT; Velilla H PA
    Rev Chilena Infectol; 2011 Dec; 28(6):572-8. PubMed ID: 22286681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sepsis-Induced Immunosuppression in Neonates.
    Hibbert JE; Currie A; Strunk T
    Front Pediatr; 2018; 6():357. PubMed ID: 30555806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cells are potent early mediators of the host response to sepsis.
    Kasten KR; Tschöp J; Adediran SG; Hildeman DA; Caldwell CC
    Shock; 2010 Oct; 34(4):327-36. PubMed ID: 20386500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Immune Cell Checkpoints during Sepsis.
    Patil NK; Guo Y; Luan L; Sherwood ER
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Immunotherapeutics for Immunosuppression in Sepsis.
    Shin J; Jin M
    Biomol Ther (Seoul); 2017 Nov; 25(6):569-577. PubMed ID: 29081088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR4: the fall guy in sepsis?
    Menassa J; Nedeva C; Pollock C; Puthalakath H
    Cell Stress; 2020 Nov; 4(12):270-272. PubMed ID: 33336149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirtuin1 Targeting Reverses Innate and Adaptive Immune Tolerance in Septic Mice.
    Martin AN; Alexander-Miller M; Yoza BK; Vachharajani V; McCall CE
    J Immunol Res; 2018; 2018():2402593. PubMed ID: 30069485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch signaling pathway regulates T cell dysfunction in septic patients.
    Jin B; Liang Y; Liu Y; Zhang LX; Xi FY; Wu WJ; Li Y; Liu GH
    Int Immunopharmacol; 2019 Nov; 76():105907. PubMed ID: 31525636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sepsis: time has come to focus on the later stages.
    Schefold JC; Hasper D; Volk HD; Reinke P
    Med Hypotheses; 2008 Aug; 71(2):203-8. PubMed ID: 18448264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells in sepsis: Potential immunoregulatory cells with therapeutic potential.
    Kumar V
    Mol Immunol; 2018 Sep; 101():615-626. PubMed ID: 30007546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenous C3 protein enhances the adaptive immune response to polymicrobial sepsis through down-regulation of regulatory T cells.
    Yuan Y; Ren J; Cao S; Zhang W; Li J
    Int Immunopharmacol; 2012 Jan; 12(1):271-7. PubMed ID: 22172643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice.
    Hotchkiss RS; Swanson PE; Cobb JP; Jacobson A; Buchman TG; Karl IE
    Crit Care Med; 1997 Aug; 25(8):1298-307. PubMed ID: 9267941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.
    Francois B; Jeannet R; Daix T; Walton AH; Shotwell MS; Unsinger J; Monneret G; Rimmelé T; Blood T; Morre M; Gregoire A; Mayo GA; Blood J; Durum SK; Sherwood ER; Hotchkiss RS
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.